4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000947871-25-001096
Director sold 33,356 shares at $44.55 ($1,486,010)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2025-12-24 | Sale 10b5-1 | −33,356 | $44.55 | $1,486,010 | 3,561,655 | I |
| Open-market sales · 33,356 sh · avg $44.55 · $1,486,010 | |||||||
Loading xslF345X05/ownership.xml…